Clinical Trials List
2025-10-01 - 2029-06-30
Phase III
Recruiting6
ICD-10C16.0
Malignant neoplasm of cardia
ICD-10C7A.092
Malignant carcinoid tumor of the stomach
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9151.0
Malignant neoplasm of cardia of stomach
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 宮慶雲 Division of General Surgery
- 吳紋綺 Division of Hematology & Oncology
- 黃宣恩 Division of Radiology
- 黃國宏 Division of General Surgery
- 方文良 Division of General Surgery
- San-Chi Chen Division of Hematology & Oncology
- 石柏軒 Division of General Surgery
- Ta-Chung Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 謝子禹 Division of Hematology & Oncology
- Tsung-Jang Yeh Division of Hematology & Oncology
- Yi-Hsun Chen Digestive System Department
- Chieh-Han Chuang Division of General Surgery
- Jeng-Shiun Du Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
- 王閔宏 Division of Hematology & Oncology
- I-CHEN WU Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 郭明濬 Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 林昶廷 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- 曾亮節 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林正純 Division of Hematology & Oncology
- 張維容 Division of Gastroenterological Surgery
- 賴冠銘 Division of Hematology & Oncology
- 石宇閎 Division of Hematology & Oncology
- 王全正 Division of Hematology & Oncology
- 張宏基 Division of Gastroenterological Surgery
- 林炫聿 Division of Hematology & Oncology
- 黃晟維 Division of Hematology & Oncology
- 林國華 Division of Gastroenterological Surgery
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林宗哲 Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- 張端瑩 Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- SUNG-HSIN KUO Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 莊建淮 Division of Hematology & Oncology
- TA-CHEN HUANG Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃培青 Division of Radiology
- 陳建銘 Division of Radiology
- Jen-Shi Chen Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Shih-Chiang Huang Division of Others -
- Wen-Chi Chou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
14-20 participants
-
Global
450 participants
